{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:16:12Z","timestamp":1793632572143,"version":"4.5.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.canep.2024.102688","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T21:28:31Z","timestamp":1729114111000},"page":"102688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Prognosis related to treatment plan in patients with biliary tract cancer: A nationwide database study"],"prefix":"10.1016","volume":"93","author":[{"given":"D.E.","family":"Renteria Ramirez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Kn\u00f8fler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kirkeg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.W.","family":"Fristrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Stender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.D.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Markussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.N.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Akdag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Al-Saffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.C.","family":"Pommergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2024.102688_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canep.2024.102688_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100378","article-title":"How I treat biliary tract cancer","volume":"7","author":"Lamarca","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.canep.2024.102688_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2024.102688_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-018-0912-x","article-title":"Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence","volume":"18","author":"Chan","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.canep.2024.102688_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"GJ. Cholangiocarcinoma-evolving concepts and therapeutic strategies","volume":"15","author":"Khan","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canep.2024.102688_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7150\/jca.68264","article-title":"The new insight of treatment in cholangiocarcinoma","volume":"13","author":"Li","year":"2022","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.canep.2024.102688_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/17474124.2021.1864325","article-title":"BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2024.102688_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/17474124.2021.1890031","article-title":"Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2024.102688_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820948047","article-title":"Immunotherapy in biliary tract cancer: worthy of a second look","volume":"27","author":"Ricci","year":"2020","journal-title":"Cancer Control"},{"key":"10.1016\/j.canep.2024.102688_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100377","article-title":"Setup of multidisciplinary team discussions for patients with cholangiocarcinoma: current practice and recommendations from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"7","author":"Casadio","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.canep.2024.102688_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1169133","article-title":"Surgical treatment for recurrent cholangiocarcinoma: a single-center series","volume":"13","author":"Fern\u00e1ndez","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.canep.2024.102688_bib12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.4251\/wjgo.v13.i11.1696","article-title":"Non-surgical treatment of hilar cholangiocarcinoma","volume":"13","author":"Inchingolo","year":"2021","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.canep.2024.102688_bib13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.21037\/jgo-20-203","article-title":"A review of systemic therapy in biliary tract carcinoma","volume":"11","author":"Jansen","year":"2020","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.canep.2024.102688_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"10.1016\/j.canep.2024.102688_bib15","doi-asserted-by":"crossref","unstructured":"Van Buuren S., Groothuis-Oudshoorn K. Journal of Statistical Software mice: Multivariate Imputation by Chained Equations in R. vol. 45. 2011.","DOI":"10.18637\/jss.v045.i03"},{"key":"10.1016\/j.canep.2024.102688_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.7150\/jca.68264","article-title":"The new insight of treatment in Cholangiocarcinoma","volume":"13","author":"Li","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.canep.2024.102688_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.963753","article-title":"Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials","volume":"12","author":"Ledenko","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.canep.2024.102688_bib18","doi-asserted-by":"crossref","first-page":"036","DOI":"10.1055\/s-0041-1730889","article-title":"Treatment outcomes of advanced cholangiocarcinoma: a single-center experience from India","volume":"11","author":"Vijayaraghavan","year":"2022","journal-title":"South Asian J. Cancer"},{"key":"10.1016\/j.canep.2024.102688_bib19","doi-asserted-by":"crossref","first-page":"14094","DOI":"10.1002\/cam4.6063","article-title":"Characteristics and clinical outcomes in young-onset cholangiocarcinoma","volume":"12","author":"Reddy","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.canep.2024.102688_bib20","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/liv.14856","article-title":"Nationwide treatment and outcomes of perihilar cholangiocarcinoma","volume":"41","author":"van Keulen","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.canep.2024.102688_bib21","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"1987"},{"key":"10.1016\/j.canep.2024.102688_bib22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canep.2024.102688_bib23","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.3390\/cancers14225580","article-title":"Gallbladder cancer: current multimodality treatment concepts and future directions","volume":"14","author":"Sturm","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canep.2024.102688_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.canep.2024.102688_bib25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ueg2.12154","article-title":"Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland","volume":"9","author":"Barner-Rasmussen","year":"2021","journal-title":"U. Eur. Gastroenterol. J."},{"key":"10.1016\/j.canep.2024.102688_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejca.2022.08.032","article-title":"Age trends in biliary tract cancer incidence by anatomical subtype: A Swedish cohort study","volume":"175","author":"Rahman","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2024.102688_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3857\/roj.2014.32.3.163","article-title":"Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma","volume":"32","author":"Jung","year":"2014","journal-title":"Radiat. Oncol. J."},{"key":"10.1016\/j.canep.2024.102688_bib28","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1038\/ajg.2014.327","article-title":"A new clinically based staging system for perihilar cholangiocarcinoma","volume":"109","author":"Chaiteerakij","year":"2014","journal-title":"Am. J. Gastroenterol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778212400167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778212400167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T06:31:13Z","timestamp":1732602673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187778212400167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":28,"alternative-id":["S187778212400167X"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2024.102688","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosis related to treatment plan in patients with biliary tract cancer: A nationwide database study","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2024.102688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102688"}}